Journal of Biopharmaceutical Statistics This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
A curtailed selection procedure for comparing Bernoulli outcomes with a control
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - March 24, 2021 Category: Statistics Authors: Chen Hsu Source Type: research
Analysis of recurrent hypoglycemic events
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - March 24, 2021 Category: Statistics Authors: Ma Qu Fu Source Type: research
A year in review: artificial intelligence permeates into mainstream statistics in pharmaceutical product development at a laggard pace
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - March 24, 2021 Category: Statistics Authors: Gamalo Source Type: research
Enhancing clarity of clinical trial safety reports for data monitoring committees
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - March 16, 2021 Category: Statistics Authors: Thomas Jung Sun Psioda Quibrera Strakowski Source Type: research
Statistical and practical considerations in designing of immuno-oncology trials
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - March 16, 2021 Category: Statistics Authors: Mukhopadhyay Huang Metcalfe Öhrn Jenner Stone Source Type: research
Power calculations for the sequential parallel comparison design with continuous outcomes
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - March 16, 2021 Category: Statistics Authors: Ivanova Qaqish Source Type: research
Sample size determination for Bayesian analysis of small n sequential, multiple assignment, randomized trials (snSMARTs) with three agents
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - March 16, 2021 Category: Statistics Authors: Wei Braun Tamura Kidwell Source Type: research
A bayesian adaptive two-stage design for pediatric clinical trials
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - March 16, 2021 Category: Statistics Authors: Psioda Xue Source Type: research
Multiplicity issues for platform trials with a shared control arm
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - March 16, 2021 Category: Statistics Authors: Bai Deng Liu Source Type: research
Design and analysis of biomarker-integrated clinical trials with adaptive threshold detection and flexible patient enrichment
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - March 16, 2021 Category: Statistics Authors: Wang Wang George Zhou Source Type: research
Futility stopping in clinical trials, optimality and practical considerations
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - March 16, 2021 Category: Statistics Authors: Chang Song Monaco Ivanova Source Type: research
Multi-stage adaptive enrichment trial design with subgroup estimation
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - March 16, 2021 Category: Statistics Authors: Joshi Nguyen Ivanova Source Type: research
The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerations
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - March 16, 2021 Category: Statistics Authors: Ivanova Israel LaVange Peters Denlinger Moore Bacharier Marquis Gotman Kosorok Tomlinson Mauger Georas Wright Noel Rosner Akuthota Billheimer Bleecker Cardet Castro DiMango Erzurum Fahy Fajt Gaston Holguin Jain Kenyon Krishnan Kraft Kumar Liu Ly Moy Phipa Source Type: research
Checkerboard: a Bayesian efficacy and toxicity interval design for phase I/II dose-finding trials
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - March 16, 2021 Category: Statistics Authors: Yin Yuan Source Type: research
The Joint i3+3 (Ji3+3) design for phase I/II adoptive cell therapy clinical trials
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - March 16, 2021 Category: Statistics Authors: Lin Ji Source Type: research